Status: Recruiting
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
A prospective, single-arm, intervention study of oral alendronate in adults with sickle cell disease and osteonecrosis
Participants needed: 30
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: University of California, DavisUpdated: Apr 13, 2026Locations: 1
Eligibility criteria
Age 18-80 years with SCD (any genotype, confirmed by hemoglobin electrophoresis... [+3]
Pregnant women [+4]